FREE COMPARISON GUIDE
Accelerate early phase oncology decisions with more insightful data
Modern data capture methods – including electronic clinical outcomes assessments, centralized digital ECGs and innovative imaging analysis methods – deliver clearer, earlier insights that support confident go/no go decisions in Phase I and II oncology trials.
Use our guide to compare modern to traditional data capture methods and make every datapoint count.
FREE COMPARISON GUIDE
Accelerate early phase oncology decisions with more insightful data
Modern data capture methods – including electronic clinical outcomes assessments, centralized digital ECGs and innovative imaging analysis methods – deliver clearer, earlier insights that support confident go/no go decisions in Phase I and II oncology trials.
Use our guide to compare modern to traditional data capture methods and make every datapoint count.
Protect patient safety
with confidence
Centralized, expert-read ECGs, alongside electronically captured patient-reported adverse event data, help sponsors understand potential safety risks earlier and with greater accuracy than traditional paper-based methods.
Here is how modern cardiac and ePRO solutions strengthen your early phase data:
- Reducing risk for unnecessary exclusion of patients due to false positive ECG data
- Minimizing inappropriate inclusion of high-risk cardiac patients
- Standardizing on-treatment cardiac data across all sites, enabling earlier identification of cardiotoxicity signals
- Allowing you to gain near real-time insight into patient-reported adverse events and treatment tolerability
Download our free guide today to compare the accuracy of modern data capture methods to traditional methods.
Detect early efficacy signals
with precision
Advanced, centralized imaging analysis brings consistency and clarity to early phase oncology trials and helps sponsors identify treatment response sooner.
The following capabilities enable earlier detection of indicators of efficacy:
- Standardized image acquisition protocols and quality control across all sites
- Blinded, centralized expert readers
- Advanced analytical tools such as tumor growth kinetics, a highly sensitive predictor of treatment response and progression compared with standard RECIST criteria
Download our free guide to compare the speed of modern data capture methods to traditional methods.
Measure patient impact
in near real time
eCOA provides near real-time access to accurate quality of life and symptomatic adverse event data to support more informed and timely decisions.
Gain faster access to patient insights that matter most:
- Near real-time capture of symptomatic adverse events
- Tolerability levels to inform dosing decisions
- More reliable insight into patient experience and burden
Download our free guide below to compare the accuracy of modern data capture methods to traditional methods.
